AEterna Zentaris News
Most Popular AEterna Zentaris Story
AEterna Zentaris shares plunge on late-stage trial failure
Shares of AEterna Zentaris went into meltdown mode after the developer announced that a closely watched Phase III trial of the benign prostatic hyperplasia drug cetrorelix had failed to hit its Read more...
Latest Headlines
- March 9, 2011
- April 16, 2010
- April 5, 2010
- December 7, 2009
- September 16, 2009
- August 17, 2009
- March 6, 2009
- November 12, 2008
- April 11, 2008
- October 3, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
